comprehensive -WSS

comprehensive

author：explore 2025-10-03 00:07:54 - browse：32398

Adobe

Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for its video game that improves symptoms of ADHD in children, on Wednesday announced it would reorient its business around selling its products directly to users over the counter, rather than by prescription.

In connection with the move away from prescription sales, Akili will reduce its workforce by 40%, which the company projects will extend its runway into the second half of 2025. The Boston-based company will continue offering its pediatric treatment, EndeavorRx, by prescription until it can convert it to over-the-counter labeling — it plans to submit data to FDA in 2024.

Akili went public last year and though its prescription sales were slowly increasing, the company’s costs far outstripped its revenues. In its second-quarter results reported in August, Akili said it earned just $114,000 on $15.3 million in expenses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Industry veterans launch new biotech VC with $310M

focus

WSS

House transparency, PBM reform bill gains bipartisan support

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Doctors' information doesn't help them choose wisely when sick

Biden report: The neurospychology of memory and aging

Medicaid rebukes states for mistakenly disenrolling children

What drug price negotiations mean for Medicare Part D

entertainment

comprehensive

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

A disappointing year of Humira biosimilars

Medicare proposal to cover medical devices draws a mixed reaction

PhRMA lawsuit over Medicare drug price negotiation tossed

Trump demands the U.S. pay no more for drugs than other countries … again

Readout LOUD podcast: How biotech is using artificial intelligence

Medical records are filled with copy

Humana sues Biden admin over Medicare Advantage audit rule

How one medical school became remarkably diverse

Medicaid rebukes states for mistakenly disenrolling children

hotspot

Amazon on where the company's health care bets are headed next

What should King Charles tell the public about his cancer?

Amazon on where the company's health care bets are headed next

How to protect patients from sexual assault

Gilead might be held responsible for not developing a drug

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

focus

focus

hotspot

leisure time